Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study will find how weight affects the dosing of a drug called anidulafungin. Currently,
the amount of anidulafungin a patient receives is the same regardless of the patient's
weight. BMI groups were for enrollment purposes only and not used for ordinal data analysis.
Phase:
Phase 4
Details
Lead Sponsor:
Texas Tech University Health Sciences Center
Collaborators:
National Center for Research Resources (NCRR) University of Texas Southwestern Medical Center